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30 or 60 minutes before, not after, coronary reperfusion is associated
with reduced infarct size, increased cardioprotective signaling, and
improved mitochondrial integrity. These preclinical ﬁndings are
supported by improved survival among patients treated with an axial
ﬂow catheter before, not after reperfusion.
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BACKGROUND Routine thrombus aspiration is superior to conven-
tional primary percutaneous coronary intervention (PCI) in terms of
improved myocardial perfusion in patients with acute myocardial
infarction with ST-segment elevation (STEMI), but its clinical useful-
ness is still questionable. Myocardial perfusion after thrombus aspi-
ration has not been evaluated by a quantitative index of
microcirculatory resistance (IMR) in a randomized fashion.
METHODS We performed a randomized, controlled clinical trial to
evaluate impact of manual thrombus aspiration (the Eliminate aspi-
ration catheter, Terumo Medical Supply, Japan) on microcirculatory
resistance after primary PCI in 128 patients with the ﬁrst STEMI
randomly assigned to thrombus aspiration or conventional primary
PCI group before coronary angiography. The primary endpoint was
deﬁned as a mean value of IMRcorr in thrombus aspiration compared
to conventional PCI group. Myocardial perfusion grade, resolution of
ST-segment elevation, enzymatic infarct size, left ventricle remodel-
ing and rate of adverse cardiac events were secondary endpoints.
RESULTS Manual thrombus aspiration, as compared with conven-
tional PCI, resulted in signiﬁcantly lower IMR corr (27.516,8 U vs.
39,932,7 U, P ¼ 0,039). Treatment with thrombus aspiration, as
compared with conventional PCI, resulted in similar rates of
myocardial perfusion grade 0 or 1 (21,5% vs. 28,6%; RR 0,75; 95% CI,
0,41 to 1,38; P¼0,36), complete resolution of ST-segment elevation
(61,5% vs. 49,2%; RR 1,25; 95% CI, 0,91 to 1,71, P¼0,16), similar infarct
size (median AUC CK-MB: 4362 U/L (IQR: 696 to 15636 U/L) versus
4401 U/L (IQR: 996 to 15657 U/L), p¼0.27), similar median value of
WMSI (1,23 vs 1,23), LV sphericity volume index (0,43 vs. 0,41) and
similar rate of LV remodeling (27,9 vs 18,5%, p¼0,21). The rate of
major adverse events (death, myocardial infarction, stroke or hospi-
talization for heart failure) between the groups was similar 4,6% vs,
11,1%, P¼0,20. In a multiple regression model with the log-trans-
formed IMR as dependent variable, after adjusting for clinical,
angiographic and procedural variables, thrombus aspiration was not
an independent predictor of lower IMR (28.4 U; 95% CI, 24.7 to 32.8 U,
vs. 32.4 U; 95% CI, 28.1 to 37.4 U; estimate 0,877, 95%CI 0,715-1,077,
P¼0.21). Histopathological examination conﬁrmed successful
thrombus aspiration in 89.6% of patients.
CONCLUSIONS Manual thrombus aspiration reduces microcirculatory
resistance indicating better myocardial perfusion compared to con-
ventional PCI in patients with STEMI. However, routine manual
thrombus aspiration is not an independent predictor of reduced
microcirculatory resistance. Reduction in microcirculatory resistance
of 12,3% achieved by routine manual aspiration is not sufﬁcient to
allow echocardiographic or clinical improvement in STEMI patients at
mid-term follow up.
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BACKGROUND The composition of thrombus in infarct-related artery
is related to the age of thrombus. It has not been analyzed the impact
of thrombus age on the efﬁcacy of manual thrombus aspiration in
STEMI patients assessed by invasive and quantitative method of
measuring microcirculatory resistance.
METHODS Out of 128 patients randomly allocated to either routine
manual thrombus aspiration or standard pPCI, 75 patients underwent
thrombus aspiration of which 10 patients had crossover. The efﬁcacy
of thrombus aspiration was assessed by determining the index of
microcirculatory circulation. The age of thrombus was assessed after
hematoxylin eosin staining. Fresh thrombi were rich in erythrocytes
with no signs of lysis of nuclei. Lytic thrombi had signs of lysis and
cardiohexia, while organized thrombi had thick collagen bands.
RESULTS In 49 patients thrombus size allowed histologic examina-
tion with hematoxillin eosin staining. Fresh thrombus was found in 25
patients and lytic or organized thrombus was found in 24 patients.
There were no differences in baseline clinical characteristics between
the group with fresh and old thrombi: 59.710.55 vs. 57.913.07,
P¼0.6, 76.0 vs. 75.8% male patients, risk factors >2 44.0 vs 16.7%,
P¼0.06, patient delay median 45 (IQR 15-127,5) vs. 60 (IQR 28.75-
222.5) min, P¼0.17, total ischemic time 166 (IQR 131.25-302.5) vs. 202,5
(IQR140.0-333.75), P¼0.21, antecedent angina 56.0 vs. 50.0%, P¼0.88,
the rate of anterior STEMI 40.0 vs. 29.2%, P¼0.63 and total ST-
segment deviation 16.28.94 vs. 16.79.91, P¼0.85, respectively.
There were no inter-group differences in angiographic and procedural
characteristics: multi vessel disease (48.0 vs. 50.0%, P¼0.69), TIMI
0 or 1 at baseline (84 vs. 87.5%, P¼0.72), TIMI 3 after completion of
pPCI (96.0 vs 91.7%, P¼0.52), thrombus length (12.38.86 vs.
12.48.12, P¼1) and ﬁnal MBG 0 or 1 (20.0% vs. 33.3%, P¼0.29). Res-
olution of ST-segment elevation (80.0 vs. 50.0%, P¼0.027) and
IMRcorr (23.213.65 vs. 37.227.32, P¼0.032) were lower in the group
with fresh thrombi compared to old thrombi. There was a trend to-
wards lower rate of distal embolizations in the group with fresh
thrombi (8.0 vs. 22.9%, P¼0.074). However, there were no differences
in infarct size (AUC CK 41542.731052.9 vs. 44712.126186.1, P¼0.71),
LVEF (55.211.67 vs. 54.010.63, P¼0.72,) WMSI (1.370.37 vs.
1.290.32) or remodeling rate (28.0 vs. 25.0%, P¼1) between the
groups with fresh and old thrombi.
CONCLUSIONS The manual aspiration of fresh thrombi leads to
improvedmyocardial perfusion in STEMI patients as comparedwith old
thrombi. However, we were unable to identify clinical or angiographic
characteristics to be associated with fresh thrombi. In addition,
improved myocardial perfusion was not associated with improved
clinical outcome in patients with fresh compared to old thrombi.
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BACKGROUND Previous studies have suggested that thyroid
dysfunction is associated with the mortality in patients with acute
myocardial infarction, but whether the thyroid function status is
associated with the prognosis of primary PCI has not been evaluated
sufﬁciently.
METHODS Consecutive 1079 patients with ST-elevation myocardial
infarction (STEMI), who were hospitalized in Fuwai hospital from
January 2010 to December 2012, were enrolled into this study. All
patients underwent primary PCI treatment and thyroid function pro-
ﬁle evaluation within the ﬁrst 12 hours after admission. The duration
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cardiovascular events (MACE), including all-cause death, non-fatal
myocardial infarction and target vessel revascularization (TVR).
RESULTS There were 149 patients with hypothyroidism (13.81%,
including low-T3 syndrome, subclinical hypothyroidism and clinical
hypothyroidism) and 16 patients with subclinical hyperthyroidism.
After adjusting for conventional risk factors (age, gender, smoke,
diabetes mellitus, dyslipidemia, hypertension), fT3 level was signiﬁ-
cantly correlated with log-CKMB (r¼-0.218, p<0.001), log-cTnI (r¼-
0.231, p<0.001), and LVEF (r¼0.463, p<0.001), indicating that the
hypothyroidism is related with myocardial injury and damaged car-
diac function. There are total 86 MACEs during two-year follow-up.
The incidence of MACEs were 14.09% in patients with hypothyroidism
and 6.99% in patients without hypothyroidism, respectively. In
multivariable Cox survival analysis, hypothyroidism is the prognostic
factor for MACE (OR: 3.7; 95%CI: 2.6-6.5) and TVR (OR: 2.3; 95%CI: 1.7-
7.2). As for non-fatal myocardial infarction, hypothyroidism was not a
signiﬁcant predictor (OR: 2.8; 95%CI: 0.6-8.9). Subclinical hyperthy-
roidism did not show any impact on prognosis.CONCLUSIONS Hypothyroidism is associated with cardiac markers
and damaged cardiac function in STEMI. In two-year follow-up, hy-
pothyroidism is a predictor for MACE and TVR in STEMI patients
treated with primary PCI. Further studies on treatment of MI with
thyroid dysfunction are needed
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BACKGROUND Triple antiplatelet therapy (TAT) including cilostazol
has showed beneﬁcial effect on mortality with safety in patients with
ST elevation myocardial infarction (STEMI) compared to dual anti-
platelet therapy (DAT). However, considering the bleeding risk in
elderly patients, it is not clear whether these beneﬁcial effects also
show or not. Thus, we compared the effect of triple antiplatelet
therapy (TAT) with DAT in elderly patients with STEMI underwent
primary percutaneous coronary intervention (PCI).
METHODS From 2007 to 2014, a total of 1401 consecutive patients
(79.6% male) with STEMI underwent primary PCI were analyzed
retrospectively. Patients were divided into two groups according to
their age (group 1: < 75 years old, group 2: 75 years old). Primary
endpoint was all-cause mortality during follow-up period.
RESULTS Of the 1401 patients, there were 1160 (82.8%, mean age
56.310.4) patients in group 1, 241 (17.2%, 80.34.5) patients in group
2. Prevalence of DM, hypertension and multi-vessel disease were
more common in group 2. In group 1, there were 235 patients (20.3%)
with TAT and 29 patients (12.0%) with TAT in group 2. Over a mean
follow-up period of 2.11.5 years, there were 90 in deaths (4.3% in
group 1 vs. 28.3% in group 2). Kaplan-Meier survival analysis revealed
that TAT was associated with lower mortality rate in group 1 (log rank
p-value¼0.023). Whereas, this beneﬁcial effect was not noted in group
2 (log rank p-value¼0.958).
CONCLUSIONS On the contrary to young patients (< 75 years old),
TAT was not associated survival beneﬁt compared to DAT in elderly
patients (75 years old) with STEMI underwent primary PCI.
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